MedWatch Technologies, Inc. — SEC Form D Filing
MedWatch Technologies, Inc. filed an SEC Form D on March 6, 2026, reporting $17.55M raised in Health Technology.
Form D filing details
- Filing
- SEC Form D
- Filing date
- March 6, 2026
- Amount reported
- $17.55M
- Round stage
- Pre-Seed
- Industry
- Health Technology
- Website
- https://medwatchtech.com/
What the company does
Securities: Equity, Debt. Exemption: Rule 506(b). Incorporated: DELAWARE
Problem
Many individuals struggle with managing their metabolic health effectively.
Solution
The company provides a non-invasive health management platform that utilizes biosensing technology and AI coaching to help users proactively manage their metabolic health.
Why now
There is a growing awareness and focus on health management, particularly in metabolic health, driving the need for innovative solutions.
Verdict
Investors said yes at that moment because MetWatch Technologies offered a relevant solution to a growing consumer concern in metabolic health, not because competitors were clearly defined. They were betting on an emerging demand for personalized health solutions coupled with an innovative use of biosensing and AI, which might have limited upside considering the risk of market saturation and the challenge of achieving consumer adoption in the wellness space.
Source: SEC EDGAR Form D filing